science1 publisher
Clearing a scar-driving macrophage reopened tumors to immunotherapy in mice
Memorial Sloan Kettering researchers used nanoparticles to kill a scar-driving macrophage subset, restoring immunotherapy in mice with liver and lung cancer. The Science paper points to the tumor's fibrotic barrier as a route past immunotherapy resistance.
Publishers:phys.org
Reality
- Evidence45
- Adoption
- Insufficient
- Hype gap+30
- Incentives55
- Confidence45